Rafael Holdings, Inc.RFL

時価総額

PER

臨床・前臨床の医薬品企業への投資持株会社の有力企業。希少疾患向け治療候補やリポソーム医薬などパイプラインを展開。2024年1月の子会社買収、2024年3月の主要持分再編、2024年8月21日の臨床会社との合併協定。米国、イスラエル、欧州を中心に展開。

概要財務

サマリーテーブルに戻る

	2018年 7月31日	2019年 7月31日	2020年 7月31日	2021年 7月31日	2022年 7月31日	2023年 7月31日	2024年 7月31日
Cash and cash equivalents	16	12	6	13	27	22	3
Available-for-sale securities	-	-	-	-	37	58	63
Interest receivable	-	-	-	-	-	-	1
Convertible note receivables, due from Cyclo	-	-	-	-	-	-	5
Accounts receivable, net	-	-	-	-	-	-	0
Prepaid expenses and other current assets	0	1	0	1	5	1	0
Convertible note receivable, related party	-	-	-	-	-	2	-
Investment in equity securities	-	-	-	-	-	0	-
Total current assets	45	13	10	15	108	83	73
Total	50	49	44	43	2	2	2
Investments	13	70	70	79	-	-	-
Convertible note receivable	-	-	-	-	-	-	1
Balance as of July 31, 2023	-	-	-	-	-	-	3
Intangible assets, net	-	-	-	-	-	-	2
In-process research and development	-	-	-	-	-	-	2
Other assets	1	1	2	2	1	0	0
TOTAL ASSETS	117	142	136	154	118	99	97
Accounts payable	0	1	1	1	1	0	3
Total accrued expenses, current	1	1	1	1	2	1	2
Convertible notes payable	-	-	-	-	-	-	1
Other current liabilities	0	0	0	0	4	1	0
Installment note payable	-	-	-	-	-	-	2
Total current liabilities	1	1	6	17	21	2	8
Accrued expenses, noncurrent	-	-	-	-	-	-	3
Deferred income tax liabilities, net	-	-	-	-	-	-	0
Other liabilities	0	0	0	0	0	0	0
TOTAL LIABILITIES	1	17	6	17	21	2	11
Class A Common Stock	0	0	0	-	-	-	0
Class B Common Stock	0	0	0	-	-	-	0
Common stock value	-	-	-	0	0	-	-
Additional paid-in capital	-	-	-	-	-	-	280
Accumulated deficit	-	-	-	-	-	-	-202
Treasury stock, at cost; 101,487 and 0 Class B shares as of July 31, 2024 and July 31, 2023, respectively	-	-	-	-	-	-	0
Accumulated other comprehensive income (loss) related to unrealized income on available-for-sale securities	-	-	-	-	-0	-0	0
Accumulated other comprehensive income related to foreign currency translation adjustment	-	-	-	-	4	4	4
Class A Common Stock	-	0	-	-	-	-	-
Class B Common Stock	-	0	-	-	-	-	-
Total equity attributable to Rafael Holdings, Inc.	116	125	131	137	101	100	86
Noncontrolling interests	9	14	14	14	-3	-4	4
Class A Common Stock	0	0	0	0	0	0	0
Class B Common Stock	0	0	0	0	0	0	0
TOTAL EQUITY	116	125	131	137	97	97	86
TOTAL LIABILITIES AND EQUITY	117	142	136	154	118	99	97